Gerresheimer with positive start to the financial year 2021
- Organic revenue growth of 3.1 % in core business
OTE0001
Gerresheimer on track for strong second half-year
- Third quarter on schedule
OTE0001
Annual General Meeting of Gerresheimer AG Approves Dividend Increase to EUR 1.20 per Share
Payment of a dividend of EUR 1.20 per share was approved at the virtual Annual General Meeting of Gerresheimer AG.
OTE0003
New Focus in Project Portfolio of Gerresheimer Subsidiary Sensile Medical
Sensile Medical, a subsidiary of Gerresheimer AG, has signed a contract with the Swiss biopharmaceutical company SQ Innovation AG for the development, market launch and mass production of a micro pump for …
OTE0003
Gerresheimer Reports Strong Second Quarter
Gerresheimer AG closed the second quarter of the financial year 2019 (March 1, 2019 to May 31, 2019) with strong revenue growth. "We had a successful second quarter.
OTE0004
Dr. Bernd Metzner to Become Chief Financial Officer of Gerresheimer AG on May 15, 2019
Dr. Bernd Metzner (48) takes up the position of Chief Financial Officer of Gerresheimer AG on May 15, 2019. Dr. Metzner had been Chief Financial Officer of SDAX-listed Ströer SE & Co. KGaA since 2014.
OTE0001
Gerresheimer Increases Revenues by 8.8% and Successfully Integrates Sensile Medical
* Revenues at constant exchange rates up 8.8% in third quarter of 2018 to EUR 364.4m
OTE0003
